Literature DB >> 383253

A critical analysis of the classifications of non-Hodgkin's lymphomas.

B N Nathwani.   

Abstract

The Rappaport classification of non-Hodgkin's lymphomas was proposed almost a quarter century ago, before the advent of modern immunology. This classification, which is based entirely on morphologic features, has proved its clinical usefulness. In light of recent scientific advances, however, its terminology is not appropriate. Five new classifications have been proposed recently, each claiming to have more merit than the others. The purpose of this study is to critically analyze and evaluate these newly proposed classifications to determine which classification is conceptually and scientifically acceptable as well as clinically useful. The results of the study show that there are more similarities than differences among the Rappaport. Lukes and Collins, Dorfman, British, and WHO classifications; the Kiel classification, however, is fundamentally different (Tables 8, 9, 11). None of these classifications can be used in its proposed form. Based on the analysis of these classifications, a compromise working classification is proposed which incorporates the relevant concepts and terminology from the Rappaport, Berard, Dorfman, WHO, and Lukes and Collins classifications (Tables 15, 16). The proposed compromise classification is an attempt to reconcile the various classifications, and to stimulate others to offer modifications which may bring about a final solution to the problem of classification of non-Hodgkin's lymphomas.

Entities:  

Mesh:

Year:  1979        PMID: 383253     DOI: 10.1002/1097-0142(197908)44:2<347::aid-cncr2820440202>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  [The history of lymphoma classifications with special consideration of cutaneous lymphomas].

Authors:  C Niermann; H J Schulze; C Hallermann
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

2.  Immunophenotypic and genotypic characterization of diffuse mixed non-Hodgkin's lymphomas.

Authors:  W E Katzin; M D Linden; A J Fishleder; R R Tubbs
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

3.  Malignant histiocytosis complicating rheumatoid arthritis: report of four cases.

Authors:  A S Jack; B F Boyce; F D Lee
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

4.  Dendritic reticulum cell-related immunostaining for laminin in follicular and diffuse B-cell lymphomas.

Authors:  A Gloghini; A Carbone
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Epithelial markers in the diagnosis of nasopharyngeal carcinoma: an immunocytochemical study.

Authors:  B A Gusterson; D P Mitchell; M J Warburton; R L Carter
Journal:  J Clin Pathol       Date:  1983-06       Impact factor: 3.411

6.  Malignant lymphomas.

Authors:  B H Tindle
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

7.  VM26 in malignant hematological diseases. A phase II study.

Authors:  U Tirelli; A Carbone; G Franchin; E Galligioni; A Veronesi; M G Trovo; R Volpe; S Tumolo; E Grigoletto
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 8.  Management of localized non-Hodgkin's lymphoma.

Authors:  R G MacKenzie; J J Rusthoven
Journal:  CMAJ       Date:  1985-09-15       Impact factor: 8.262

Review 9.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

10.  Morphometric characterization of diffuse large-cell (histiocytic) lymphomas.

Authors:  P van der Valk; J Hermans; R Brand; C J Cornelisse; P J Spaander; C J Meijer
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.